Back
Corbus Pharmaceuticals Holdings Vs. Protalix BioTherapeutics Industry Stock Comparison
Buy
62
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
42.93
Seasonality Move:
-8.14%
Sell
48
PLX
Protalix BioTherapeutics
Last Price:
1.15
Seasonality Move:
0.94%
Buy
62
Corbus Pharmaceuticals Holdings (CRBP)
is a Buy
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $42.87. The Score for CRBP is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- CRBP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Protalix BioTherapeutics (PLX)
is a Sell
Is Protalix BioTherapeutics a Buy, Sell or Hold?
- The current Protalix BioTherapeutics [PLX] share price is $1.14. The Score for PLX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- PLX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $42.87
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRBP is experiencing slight selling pressure.
PLX Stock Price Chart
What is Protalix BioTherapeutics's stock price today?
-
The Protalix BioTherapeutics share price today is $1.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLX is experiencing slight selling pressure.
CRBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.36 | Buy |
| Relative Strength Index (14 RSI): | 62.03 | Buy |
| Chaikin Money Flow: | -27023 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.04 - 41.5) | Buy |
| Bollinger Bands (100): | (13.82 - 41.2) | Buy |
PLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 45.87 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.12 - 1.22) | Sell |
| Bollinger Bands (100): | (1.21 - 1.63) | Sell |
CRBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.93 | Buy |
| 20-day SMA: | 38.51 | Buy |
| 50-day SMA: | 39.08 | Buy |
| 200-day SMA: | 16.74 | Buy |
| 8-day EMA: | 41.22 | Buy |
| 20-day EMA: | 39.51 | Buy |
| 50-day EMA: | 36.33 | Buy |
| 200-day EMA: | 21.87 | Buy |
PLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.15 | Sell |
| 20-day SMA: | 1.16 | Sell |
| 50-day SMA: | 1.26 | Sell |
| 200-day SMA: | 1.54 | Sell |
| 8-day EMA: | 1.15 | Sell |
| 20-day EMA: | 1.17 | Sell |
| 50-day EMA: | 1.25 | Sell |
| 200-day EMA: | 1.49 | Sell |
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.55 per share, an increase next quarter of $0.28 per share, an increase this year of $5.53 per share, and an increase next year of $0.35 per share.
Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corbus Pharmaceuticals Holdings Technical Analysis
| Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Protalix BioTherapeutics Technical Analysis
| Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||